The B12 in your compounded formulation should keep serum B12 levels adequate in most cases, but "most cases" is not "all cases." Verify with bloodwork rather than assuming
Weeks 1 to 4: Starting Dose Titration Starting dose is 0.25 milligrams of semaglutide weekly, plus 1,000 micrograms of B12
Stability Comparison Storage Requirements by Type The fragility of first-generation GHK-CU explains why proper storage matters so much for this particular peptide
Providers practicing in multiple jurisdictions must be aware of varying regulatory requirements
The peptide works best as part of a comprehensive approach addressing all aspects of recovery
Common adverse effects include: Injection site reactions pain, redness, swelling, or bruising at the intramuscular injection site Gastrointestinal disturbances nausea, diarrhoea, or abdominal discomfort Headache and dizziness particularly following initial doses Skin reactions including rash, pruritus, or acne-like eruptions Flushing temporary redness of the skin Chromaturia red-coloured urine (harmless but can cause concern if unexpected) Less common but more serious reactions include: Hypersensitivity reactions ranging from mild urticaria to anaphylaxis (rare but potentially life-threatening) Hypokalaemia particularly during initial treatment when rapid cell production occurs [5] [16] Temporary changes in blood counts during correction of deficiency Interference with laboratory tests primarily with high-dose IV hydroxocobalamin used for cyanide poisoning, not typically with standard 1mg IM replacement doses Cautions and contraindications: Hypersensitivity to cobalt or vitamin B12 Cyanocobalamin should be avoided in Leber's hereditary optic neuropathy [2] [17] Chloramphenicol may reduce the haematological response to B12 therapy Patients receiving B12 injections outside clinical necessity face unnecessary risks without proven benefit
